Rhizarthrosis Clinical Trial
Official title:
Biological Characterization Study of an Autograft Nanofat (Nanocarabio)
Rhizarthrosis (trapeziometacarpal osteoarthritis) is the most common primary osteoarthritis of the hand, and a source of major functional impact, as it affects the thumb. Non-surgical therapeutic means are currently limited to wearing an immobilization splint, analgesics and oral non-steroidal anti-inflammatory drugs. These symptomatic treatments are of limited effectiveness and do not prevent from progression of the osteoarthritis disease. The most effective treatments currently recognized are surgical, but they also have their limits. Cell therapy is considered as a promising approach to treat tissue damage including osteoarthritis. Mesenchymal stromal cells are excellent candidates for achieving this type of result, because they can differentiate into the different tissues from the mesoderm (cartilage, bone, muscle, tendons, fat, dermis, conjunctive matrix, etc.). In addition, unlike cells from the embryonic cord, the risk of teratoma or tumor does not exist. Mesenchymal stem cells have regenerative and immunomodulatory properties but the methods of collection, preparation, combination with substances such as hyaluronic acid, or PRP, or platelet concentrates, will obviously influence the effectiveness of the results. . Nanofat autografts are obtained in a simple way, in a closed circuit, preserving the stromal mesenchymal cells in large numbers with a minimum impact on the cellular elements. The preparation remains simple and inexpensive, but it is nevertheless necessary to characterize these emulsified preparations biologically before using them as cell therapy. The main objective of this study is to characterize a nanofat autograft on a biological level.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04829565 -
Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb
|
Phase 4 | |
Recruiting |
NCT05047744 -
Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis
|
N/A | |
Active, not recruiting |
NCT04115085 -
Study of Medical Ultrasound for Rhizarthrosis
|
N/A | |
Recruiting |
NCT06078189 -
Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy
|
||
Completed |
NCT03320291 -
Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis
|
N/A | |
Completed |
NCT04587570 -
Rhizarthrosis Study
|
N/A | |
Completed |
NCT02676284 -
Durolane SJ for Treatment of Rhizarthrosis
|
N/A | |
Recruiting |
NCT05597930 -
New 3D Printed Wrist Orthosis
|
N/A | |
Completed |
NCT03431584 -
Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis.
|
Phase 4 | |
Active, not recruiting |
NCT03089723 -
Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis
|
N/A | |
Recruiting |
NCT01233739 -
Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis.
|
Phase 4 | |
Not yet recruiting |
NCT04588961 -
Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis
|
N/A | |
Terminated |
NCT03020368 -
Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint
|
N/A | |
Completed |
NCT05169099 -
Post-operative Results of the Trapezometacarpal (TMC) Prosthesis for Advanced Pre-operative Deformities
|
||
Recruiting |
NCT03879434 -
Routine Application of Ostenil® Mini in Patients With Rhizarthrosis
|
||
Not yet recruiting |
NCT05708430 -
Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis
|
Phase 2 |